Pancreatic Cancer Resource Center

pancreatic cancer

Diversity in Pancreatic Cancer Clinical Trials Remains Low

Diversity within pancreatic cancer clinical trials has not improved over the past 15 years, according to a new study published in Gastroenterology. Researchers from the...
hematology oncology news cancer news

Hem/Onc Roundup: BCMA CAR T Approved for MM, Disparities Remain in Breast Cancer Screening

This week, the U.S. FDA approved idecabtagene vicleucel (ide-cel) for the treatment of adults with relapsed/refractory multiple myeloma following four or more previous treatments....

Surgery Viable Treatment for Pancreatic Cancer Patients Following Chemotherapy

Surgery is an underused, and viable treatment option for patients with stage II pancreatic cancer, according to a study published in the Journal of...

Second-Line Therapy Outcomes in Metastatic Pancreatic Cancer

A study published in ESMO Open evaluated outcomes of second-line chemotherapy combinations for patients with metastatic pancreatic cancer who had failed on first-line treatments. “There...
Adjuvant Chemotherapy After Neoadjuvant FOLFIRINOX Treatment Beneficial for Some Pancreatic Cancer Patients—But Not All

Case Study: Impact of COVID-19 on Pancreatic Cancer Surgery Outcomes

A study published in In Vivo evaluated the impact of COVID-19 infection on postoperative outcomes in patients with pancreatic cancer. The case study included three...
hematology oncology news cancer news

Hem/Onc Roundup: Eliminating Disparity in MM Trials; Plus, Cancer Care in the Pandemic

This week, researchers from the Dana-Farber Cancer Institute collaborated with the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research...
Chronic Pain Reported in 1 in 3 Cancer Survivors

Pancreatic Cancer Mortality Predicted to Rise Among Women

Rates of mortality due to pancreatic cancer were not predicted to improve across Europe in 2021, and may even increase among women, according to...

Curated Journal Reading List